Ridaura
Product Images NDC 65483-093

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ridaura (NDC 65483-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prometheus Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rid01 0003 01)

Chemical structure of a compound containing gold (Au) bound to a phosphorus (P) atom connected to ethyl groups, and a carbohydrate backbone with multiple acetyl groups. This structure is consistent with the active ingredient in RIDAURA (auranofin).*

FDA Label Image

Principal Display Panel – 3 mg Bottle Label (Rid01 0003 02)

RIDAURA Auranafin Capsules label showing 3 mg strength with a count of 60 capsules. The label includes storage instructions, dosage information, and safety warnings. Manufactured by Prometheus Laboratories Inc., San Diego, CA. Background gradient blends teal and pink with white text and a small red banner indicating the strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.